Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
All eyes are on Hong Kong's Kuaishou Technology (1024 HK) IPO. It was reported that the deal was 1,200x oversubscribed, topping out Nongfu Spring's mega IPO demand. IPO performance of the company will likely set the tone for other mega Hong Kong IPOs, at least for the first half of this year. Read more about our final take on valuation, index flows and other deal dynamics in:
Meanwhile, we continue to see an influx of IPOs launching their bookbuild, probably looking to come to market before Chinese New Year. This week we had Basecare Medical Device Co L (1537404D CH) and MicroPort CardioFlow (1844972D HK) launched their IPO bookbuild. The former closed its books early while the latter was said to have priced at the top-end. We are also hearing that Dida (DIDA HK) is likely to come to market in February. We share our thoughts on peer comparison, forecasts and valuation.
India IPO deal flow is still looking strong too. Brookfield India Real Estate Trust (BIREIT IN) is looking to open its books this coming Wednesday whereas Indigo Paints (IP IN) will list on Tuesday. Indian Railway Finance Corporation (INFZ IN) debuted on Friday with a lacklustre performance which was expected of a company that is essentially a regulated entity with pre-ordained returns and has no real say in its own future.
Further way from home, in the US, we are hearing that Cloopen Group Holding Ltd (RAAS US) was premarketing this week and looking to open books next week. We looked at the company's business and operational data in:
Placements this week.
Our overall accuracy rate is 73.7% for IPOs and 67.2% for Placements
(Performance measurement criteria is explained at the end of the note)
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.